Negative Signs and Symptoms Secondary to Antipsychotics: A Double-Blind, Randomized Trial of a Single Dose of Placebo, Haloperidol, and Risperidone in Healthy Volunteers - Artaloytia, Juan Francisco; Arango, Celso; Lahti, Adrienne; Sanz, Javier; Pascual, Ana; Cubero, Pedro; Prieto, David; Palomo, Tomás (The American journal of psychiatry, 2006)
Keywords: Adolescent; Adult; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Basal Ganglia Diseases - chemically induced; Basal Ganglia Diseases - diagnosis; Basal Ganglia Diseases - epidemiology; Behavioral Symptoms - chemically induced; Behavioral Symptoms - diagnosis; Behavioral Symptoms - epidemiology; Biological and medical sciences; Brief Psychiatric Rating Scale; Clinical trials; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug therapy; Female; Haloperidol - adverse effects; Haloperidol - therapeutic use; Health Status; Hospitals; Humans; Male; Medical sciences; Middle Aged; Neuropharmacology; Patients; Pharmaceutical industry; Pharmacology. Drug treatments; Placebos; Psychiatric Status Rating Scales - statistics & numerical data; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Risperidone - adverse effects; Risperidone - therapeutic use; Schizophrenia; Schizophrenia - diagnosis; Schizophrenia - drug therapy; Schizophrenic Psychology; Sleep Stages - drug effects; Surveys and Questionnaires; Atypical antipsychotic; Healthy subject; Neuroleptic; Psychotropic; Dopamine antagonist; Serotonin antagonist; Butyrophenone derivatives; Serotonine receptor; Haloperidol; Psychosis; Chemotherapy; D2 Dopamine receptor; Treatment; Negative symptom; Placebo; Double blind study; Risperidone